1. Home
  2. NMRA vs LOMA Comparison

NMRA vs LOMA Comparison

Compare NMRA & LOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • LOMA
  • Stock Information
  • Founded
  • NMRA 2019
  • LOMA 1926
  • Country
  • NMRA United States
  • LOMA Argentina
  • Employees
  • NMRA N/A
  • LOMA N/A
  • Industry
  • NMRA
  • LOMA Building Materials
  • Sector
  • NMRA
  • LOMA Industrials
  • Exchange
  • NMRA Nasdaq
  • LOMA Nasdaq
  • Market Cap
  • NMRA 1.7B
  • LOMA 1.5B
  • IPO Year
  • NMRA 2023
  • LOMA 2017
  • Fundamental
  • Price
  • NMRA $2.05
  • LOMA $10.76
  • Analyst Decision
  • NMRA Strong Buy
  • LOMA Sell
  • Analyst Count
  • NMRA 6
  • LOMA 2
  • Target Price
  • NMRA $20.67
  • LOMA $6.55
  • AVG Volume (30 Days)
  • NMRA 6.3M
  • LOMA 543.4K
  • Earning Date
  • NMRA 03-06-2025
  • LOMA 03-05-2025
  • Dividend Yield
  • NMRA N/A
  • LOMA N/A
  • EPS Growth
  • NMRA N/A
  • LOMA N/A
  • EPS
  • NMRA N/A
  • LOMA 0.63
  • Revenue
  • NMRA N/A
  • LOMA $265,542,171.00
  • Revenue This Year
  • NMRA N/A
  • LOMA N/A
  • Revenue Next Year
  • NMRA N/A
  • LOMA N/A
  • P/E Ratio
  • NMRA N/A
  • LOMA $17.10
  • Revenue Growth
  • NMRA N/A
  • LOMA N/A
  • 52 Week Low
  • NMRA $1.83
  • LOMA $5.70
  • 52 Week High
  • NMRA $21.00
  • LOMA $13.79
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 20.26
  • LOMA 37.02
  • Support Level
  • NMRA $2.12
  • LOMA $11.50
  • Resistance Level
  • NMRA $2.44
  • LOMA $12.34
  • Average True Range (ATR)
  • NMRA 0.39
  • LOMA 0.65
  • MACD
  • NMRA -0.31
  • LOMA -0.23
  • Stochastic Oscillator
  • NMRA 2.26
  • LOMA 5.86

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue Derives from Cement, masonry cement, and lime segment.

Share on Social Networks: